ConcertAI & PathAI Partner Creating First-in-Class Histopathology and Curated Clinical RWD Product

 Read More

ConcertAI and Caris Life Sciences Form Partnership Creating Industry’s Largest Molecular Oncology Research Biopharma Platform

 Read More

Bristol Myers Squibb and ConcertAI Advance Novel Oncology Accelerated Digital Clinical Trial Solution

 Learn More

QCCA and ConcertAI Partner on Novel Digital Clinical Trial Solutions

 Learn More

ConcertAI Expands Partnership with Janssen Pharmaceuticals

 Learn More

FDA Collaboration to Advance Use of RWE

 Learn More

Erace

Promoting Cancer Health Equity

 Learn More

Commercial Solutions to Increase Patient Adherence

 Learn More

 

Making Equity and Trial Diversity Real

a Blog by Jeff Elton, CEO

Independent, Scalable and Specialized

The Industry’s Largest U.S. Oncology RWD

See Our Data
 
0+

EMR Systems

0+

AI Models

0+

Medical Oncologists

0+

Provider Cancer Clinics

Frequent

Data Refreshes

The ConcertAI Podcast is now live! Listen on your preferred platform or click the link below.

Click to listen now!

See All Events
Events

ASCO Annual Meeting 2023

June 2, 2023

This year at ASCO we will feature advances in our Patient360™ RWD solution, translational medical platform in partnership with CARIS Life Sciences and Digital Trial Solutions; just to name a few. Click to set up a meeting in advance or visit our booth #4049. We look forward to seeing you there!

Learn More

Leading Biopharma Choose ConcertAI

Press Release

ConcertAI Expands Data Science Collaboration with Janssen to Drive Effective Therapies and Address Health Disparities in Clinical Trials

Read More
Press Release

Concerto HealthAI Enters Precision Oncology Collaboration with Pfizer

Read More
Press Release

Bristol-Myers Squibb and Concerto HealthAI Announce Strategic Agreement to Broaden Uses of RWE and Accelerate Precision Oncology Innovations

Read More
Clinical Development

For Improved Patient Outcomes in Oncology

Our experienced team of scientists work with our data and AI technologies to accelerate trial data analysis and to help you implement novel data and analytics techniques for RCTs, pragmatic trials, external controls, or adaptive studies.
Our experienced team of scientists work with our data and AI technologies to accelerate trial data analysis and to help you implement novel data and analytics techniques for RCTs, pragmatic trials, external controls, or adaptive studies.
COMMERCIAL SOLUTIONS

Drive Better
Patient Outcomes
for Diseases

Learn More
  • AML
  • Breast Cancer
  • Cirrhosis
  • Fabry Disease
  • GIST
  • Hemophilia
  • Hepatitis C
  • Leukemia
  • Multiple Sclerosis
  • Myelofibrosis
  • Plaque Psoriasis
  • Prostate Cancer
  • Pulmonary Arterial Hypertension
  • Rheumatoid Arthritis
  • Schizophrenia
  • Tardive Dyskinesia

News & Highlights

Home
News

ConcertAI Announces Integration of Terarecon

Learn More
Home
Announcement

ConcertAI Raises 150 Million Series C from Sith Street at 1.9 Billion Valuation

Read More
Home
Press Release

ConcertAI Awarded 2022-23 Great Place to Work Certification™

Read More

Innovate with ConcertAI – We’re hiring!

Join the fastest growing AI-powered SaaS and data company in healthcare. We are looking for motivated, curious, independent people dedicated to transforming how healthcare is delivered. Talk to us about how to make an impact.

View Open Jobs